João Passos1, Hipólito Nzwalo2, Mariana Valente1, Joana Marques1, Ana Azevedo1, Eduardo Netto3, António Mota3, Alexandra Borges4, Sofia Nunes5, Duarte Salgado6. 1. Neurology Department, Instituto Português de Oncologia de Lisboa Francisco Gentil, Portugal. 2. Biomedical Science and Medicine Department, Universidade do Algarve, Portugal. Electronic address: nzwalo@gmail.com. 3. Radiotherapy Department, Instituto Português de Oncologia de Lisboa Francisco Gentil, Portugal. 4. Radiology Department, Instituto Português de Oncologia de Lisboa Francisco Gentil, Portugal. 5. Paediatric Department, Instituto Português de Oncologia de Lisboa Francisco Gentil, Portugal; Paediatric Neuro-Oncology Unit, Instituto Português de Oncologia de Lisboa Francisco Gentil, Portugal. 6. Neurology Department, Instituto Português de Oncologia de Lisboa Francisco Gentil, Portugal; Paediatric Department, Instituto Português de Oncologia de Lisboa Francisco Gentil, Portugal.
Abstract
BACKGROUND: With the expected growth and aging of the population of primary central nervous system tumours (PCNST) survivors, attention to the radiation-induced late brain injury is fundamental. Late focal hemosiderin deposition (FHD) lesions, namely microbleeds and cavernomas, are among the presumable late cerebrovascular complications associated with radiotherapy for PCNST. OBJECTIVE: To explore association between PCNST radiotherapy and the occurrence FHD lesions and to address the correlation between the topographic location of these microvascular lesions with the focal radiotherapy location. METHODS: Retrospective cohort study of 190 paediatric patients being followed for PCNST in a single referral oncological centre. The frequency of FHD lesions was compared between paediatric PCNST treated (n=132) and not treated (n=58) with brain radiation. Microbleed Anatomical Rating Scale (MARS) was used for systematic identification of these cerebrovascular lesions and to address the consistency between the topographic location of each lesion and the location of the focal radiotherapy area. Univariate analysis to address the role of variables such as tumour histology, location, gender and age of children at the beginning of radiotherapy, duration of follow-up and chemotherapy was performed. RESULTS: FHD lesions (microbleeds and cavernomas) occurred exclusively and in a high percentage (41.6%) in PCNST survivors treated with brain radiation. Younger age at the diagnosis (p=0.031), duration of follow-up (p=0.010) and embryonal histology (p=0.003) positively correlated with the occurrence FHD lesions. FHD lesions were topographically concordant with the brain focal irradiation area in 3/19 (15.8%) patients from the focal RT subgroup and in 22/111 (19.8%) patients from the WBRT plus focal RT subgroup. CONCLUSION: Our study, which is one of the largest to date on the topic, shows that FHD lesions are a common complication after radiotherapy for childhood PCNST. The young brain is probably more susceptible to radiation-induced late cerebrovascular injury. Diffuse small vessel disease and ceiling effect may account for the low topographic concordance we found. The clinical implications of FHD lesions in this specific population are yet to be clarified.
BACKGROUND: With the expected growth and aging of the population of primary central nervous system tumours (PCNST) survivors, attention to the radiation-induced late brain injury is fundamental. Late focal hemosiderin deposition (FHD) lesions, namely microbleeds and cavernomas, are among the presumable late cerebrovascular complications associated with radiotherapy for PCNST. OBJECTIVE: To explore association between PCNST radiotherapy and the occurrence FHD lesions and to address the correlation between the topographic location of these microvascular lesions with the focal radiotherapy location. METHODS: Retrospective cohort study of 190 paediatric patients being followed for PCNST in a single referral oncological centre. The frequency of FHD lesions was compared between paediatric PCNST treated (n=132) and not treated (n=58) with brain radiation. Microbleed Anatomical Rating Scale (MARS) was used for systematic identification of these cerebrovascular lesions and to address the consistency between the topographic location of each lesion and the location of the focal radiotherapy area. Univariate analysis to address the role of variables such as tumour histology, location, gender and age of children at the beginning of radiotherapy, duration of follow-up and chemotherapy was performed. RESULTS:FHD lesions (microbleeds and cavernomas) occurred exclusively and in a high percentage (41.6%) in PCNST survivors treated with brain radiation. Younger age at the diagnosis (p=0.031), duration of follow-up (p=0.010) and embryonal histology (p=0.003) positively correlated with the occurrence FHD lesions. FHD lesions were topographically concordant with the brain focal irradiation area in 3/19 (15.8%) patients from the focal RT subgroup and in 22/111 (19.8%) patients from the WBRT plus focal RT subgroup. CONCLUSION: Our study, which is one of the largest to date on the topic, shows that FHD lesions are a common complication after radiotherapy for childhood PCNST. The young brain is probably more susceptible to radiation-induced late cerebrovascular injury. Diffuse small vessel disease and ceiling effect may account for the low topographic concordance we found. The clinical implications of FHD lesions in this specific population are yet to be clarified.
Authors: Cassie Kline; Schuyler Stoller; Lennox Byer; David Samuel; Janine M Lupo; Melanie A Morrison; Andreas M Rauschecker; Pierre Nedelec; Walter Faig; Dena B Dubal; Heather J Fullerton; Sabine Mueller Journal: Front Oncol Date: 2022-06-23 Impact factor: 5.738
Authors: Tiina Maria Remes; Maria Helena Suo-Palosaari; Päivi K T Koskenkorva; Anna K Sutela; Sanna-Maria Toiviainen-Salo; Pekka M Arikoski; Mikko O Arola; Vesa-Pekka Heikkilä; Mika Kapanen; Päivi Maria Lähteenmäki; Tuula R I Lönnqvist; Hannele Niiniviita; Tytti M-L Pokka; Liisa Porra; V Pekka Riikonen; Jan Seppälä; Kirsti H Sirkiä; Antti Vanhanen; Heikki M J Rantala; Arja H Harila-Saari; Marja K Ojaniemi Journal: Neurooncol Pract Date: 2020-02-07
Authors: Nicholas S Phillips; Claudia M Hillenbrand; Bogdan G Mitrea; Jason Yan; Chenghong Li; Matthew A Scoggins; Thomas E Merchant; Gregory T Armstrong; Deokumar Srivastava; Ching-Hon Pui; Leslie L Robison; Melissa M Hudson; Kevin R Krull; Noah D Sabin Journal: Sci Rep Date: 2020-01-20 Impact factor: 4.379